Joost Verbeek
Joost Verbeek
radiochemist, vu university medical center amsterdam
確認したメール アドレス: quicknet.nl
タイトル
引用先
引用先
Evaluation of [11C] laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats
G Luurtsema, RC Schuit, RP Klok, J Verbeek, JE Leysen, ...
Nuclear medicine and biology 36 (6), 643-649, 2009
772009
[11C] phenytoin revisited: synthesis by [11C] CO carbonylation and first evaluation as a P-gp tracer in rats
J Verbeek, J Eriksson, S Syvänen, M Labots, E de Lange, RA Voskuyl, ...
EJNMMI research 2 (1), 1-11, 2012
422012
Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C] benzyl]-morpholine: evaluation of a potential PET ligand
AJ Airaksinen, JA Jablonowski, M van der Mey, AJ Barbier, RP Klok, ...
Nuclear medicine and biology 33 (6), 801-810, 2006
372006
Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl …
R Al Hussainy, J Verbeek, D van der Born, AH Braker, JE Leysen, RJ Knol, ...
Journal of medicinal chemistry 54 (10), 3480-3491, 2011
332011
[11C] quinidine and [11C] laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness
S Syvänen, V Russmann, J Verbeek, J Eriksson, M Labots, C Zellinger, ...
Nuclear medicine and biology 40 (6), 764-775, 2013
282013
Quantification of dynamic 11C-phenytoin PET studies
S Mansor, R Boellaard, FE Froklage, EDM Bakker, M Yaqub, RA Voskuyl, ...
Journal of Nuclear Medicine 56 (9), 1372-1377, 2015
252015
Carbon-11 labeled tracers for in vivo imaging of P-glycoprotein function: kinetics, advantages and disadvantages
G Luurtsema, J Verbeek, M Lubberink, A A Lammertsma, R Dierckx, ...
Current topics in medicinal chemistry 10 (17), 1820-1833, 2010
252010
Synthesis and preclinical evaluation of [11C] D617, a metabolite of (R)-[11C] verapamil
J Verbeek, S Syvänen, RC Schuit, J Eriksson, EC de Lange, ...
Nuclear medicine and biology 39 (4), 530-539, 2012
202012
Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl) piperazin-1-yl] ethyl}-N-(pyridin-2-yl) cyclohexanecarboxamide (WAY …
R Al Hussainy, J Verbeek, D van der Born, J Booij, JKDM Herscheid
European journal of medicinal chemistry 46 (12), 5728-5735, 2011
192011
Recent progress in metal catalyzed direct carboxylation of aryl halides and pseudo halides employing CO2: opportunities for 11C radiochemistry
M Ahamed, J Verbeek, U Funke, J Lecina, A Verbruggen, G Bormans
ChemCatChem 8 (24), 3692-3700, 2016
182016
Synthesis, biodistribution and PET studies in rats of 18F-Labeled bridgehead fluoromethyl analogues of WAY-100635
R Al Hussainy, J Verbeek, D van der Born, C Molthoff, J Booij, ...
Nuclear medicine and biology 39 (7), 1068-1076, 2012
92012
Development and characterization of [123I] iodotiagabine for in-vivo GABA-transporter imaging
O Schijns, M van Kroonenburgh, F Beekman, J Verbeek, J Herscheid, ...
Nuclear medicine communications 34 (2), 175-179, 2013
82013
Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237)
JACM Goos, J Verbeek, AA Geldof, AC Hiemstra, MA van de Wiel, ...
Nuclear medicine and biology 43 (1), 63-72, 2016
72016
The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors
AJ Thompson, MHP Verheij, J Verbeek, AD Windhorst, IJP de Esch, ...
Neuropharmacology 86, 378-388, 2014
72014
Sharing and collecting hospital-based health technology assessment reports internationally: is an extensive participation of stakeholders realistic?
J Verbeek, M Hiligsmann, A Cicchetti, M Marchetti
International journal of technology assessment in health care 34 (5), 527-534, 2018
62018
Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([18 F] 4FIMPTC) as a novel PET tracer of P-glycoprotein …
J Verbeek, J Eriksson, S Syvänen, M Huisman, RC Schuit, CFM Molthoff, ...
EJNMMI radiopharmacy and chemistry 3 (1), 1-19, 2018
42018
Parametric methods for dynamic 11C-phenytoin PET studies
S Mansor, M Yaqub, R Boellaard, FE Froklage, A De Vries, EDM Bakker, ...
Journal of Nuclear Medicine 58 (3), 479-483, 2017
22017
Initial evaluation of P2X (7) R antagonists [C-11] A-740003 and [C-11] SMW64-D16 as PET tracers of microglial activation in neuroinflammation
B Janssen, D Ory, SM Wilkinson, DJ Vugts, EJ Kooijman, J Verbeek, ...
Journal Of Labelled Compounds & Radiopharmaceuticals 58, S277-S277, 2015
22015
[C-11] Phenytoin is a weak P-glycoprotein substrate in rat-Initial PET studies
M Labots, J Verbeek, J Eriksson, EC de Lange, RC Schuit, M Rongen, ...
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 54, S286-S286, 2011
22011
Synthesis and biological evaluation of [11C] D617, a metabolite of [11C] verapamil
J Verbeek, AD Windhorst, J Eriksson, AA Lammertsma, G Luurtsema
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 52, S338-S338, 2009
22009
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20